Evaluation on Efficacy of Total Artificial Disc Replacement (TDR) of Cervical Spondylosis

NCT03364816 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2017-12-07

No results posted yet for this study

Summary

To evaluate the efficacy of 3 different types of cervical disc prosthesis (Prodisc-C, Mobi-C and Prestige-LP) in the treatment of cervical spondylosis.

Conditions

  • Cervical Spondylosis

Interventions

PROCEDURE

TDR

total artificial disc replacement

Sponsors & Collaborators

  • Peking University People's Hospital

    lead OTHER

Principal Investigators

  • Zhenqi Zhu · Department of spinal surgery

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2018-12-31
Completion
2018-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364816 on ClinicalTrials.gov